Cowen assumed coverage on shares of Randsburg International Gold (OTCMKTS:CRLBF) in a research note issued to investors on Friday morning, BenzingaRatingsTable reports. The firm issued an outperform rating and a $14.00 target price on the stock.
CRLBF has been the topic of a number of other research reports. Compass Point started coverage on Randsburg International Gold in a research note on Monday, June 10th. They issued a buy rating on the stock. Piper Jaffray Companies started coverage on Randsburg International Gold in a research note on Monday, August 12th. They issued an overweight rating and a $11.00 target price on the stock.
Shares of OTCMKTS CRLBF opened at $7.91 on Friday. Randsburg International Gold has a twelve month low of $4.19 and a twelve month high of $14.39. The business has a 50 day simple moving average of $8.28.
Cresco Labs Inc manufactures and sells medical cannabis products in the United States. It offers cannabis dry flower; vaporizer forms of cannabis; cannabis oil in capsule, oral and sublingual solutions; cannabis in topical; and other cannabis products. The company also provides cannabis infused edibles, including chocolate and toffee confections, fruit-forward gummies, and hard sweet and chews.
Featured Article: Different Types of Derivatives
Receive News & Ratings for Randsburg International Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Randsburg International Gold and related companies with MarketBeat.com's FREE daily email newsletter.